These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3539687)

  • 21. What have clinical trials taught us about proarrhythmia?
    Skanes AC; Green MS
    Can J Cardiol; 1996 Apr; 12 Suppl B():20B-26B. PubMed ID: 8616725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Results of the clinical study of a new anti-arrhythmia preparation allapinin].
    Mazur NA; Ivanova LA; Pavlova TS
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):30-3. PubMed ID: 3541962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical experience with lorcainide (R 15 889), a new anti-arrhythmic drug.
    Kesteloot H; Stroobandt R
    Arch Int Pharmacodyn Ther; 1977 Dec; 230(2):225-34. PubMed ID: 603318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the antiarrhythmic activity of mexiletine and lorcainide on ventricular arrhythmias.
    Meinertz T; Kasper W; Stengel E; Waldecker B; Löllgen H; Jähnchen E; Bechtold H; Just J
    Z Kardiol; 1982 Jan; 71(1):35-8. PubMed ID: 7039160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Monitoring anti-arrhythmic therapy with dynamic ECG and serum levels].
    Meoli P; Sanna GP; Cataldo G; Massa D; Brusoni B
    Boll Soc Ital Cardiol; 1980; 25(9):1081-3. PubMed ID: 7284197
    [No Abstract]   [Full Text] [Related]  

  • 26. [Comparative evaluation of the anti-arrhythmia effectiveness of mezotrin and izoptin].
    Dzhishambaev ED; Ivanova LA; Bugriĭ EM; Mazur NA; Pavlova TS
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):40-4. PubMed ID: 3541963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New concepts for antiarrhythmic drugs in the 1980's.
    Harrison DC; Irwin WG
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():73-7. PubMed ID: 6803704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The pro-arrhythmic effects of anti-arrhythmia agents].
    Haverkamp W; Wichter T; Chen X; Hördt M; Willems S; Rotman B; Hindricks G; Kottkamp H; Borggrefe M; Breithardt G
    Z Kardiol; 1994; 83 Suppl 5():75-85. PubMed ID: 7846949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New drugs in the management of ventricular arrhythmias.
    Sanna GP
    G Ital Cardiol; 1984 Oct; 14(10):788-97. PubMed ID: 6083894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Limits of quantitative evaluation methods].
    Coumel P; Leclercq JF; Attuel P
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():103-12. PubMed ID: 6176205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Future of antiarrhythmic drugs.
    Darbar D; Roden DM
    Curr Opin Cardiol; 2006 Jul; 21(4):361-7. PubMed ID: 16755206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiarrhythmic effect related to the plasma concentration of pentisomide in vivo and the antiarrhythmic-concentration relationship in vitro.
    Hachisu M; Chen H; Soneda T; Fujishima K; Ishizuka T; Konno F
    Drugs Exp Clin Res; 1995; 21(4):145-51. PubMed ID: 8529527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Individual patterns of dynamic QT/RR relationship in survivors of acute myocardial infarction and their relationship to antiarrhythmic efficacy of amiodarone.
    Smetana P; Pueyo E; Hnatkova K; Batchvarov V; Laguna P; Malik M
    J Cardiovasc Electrophysiol; 2004 Oct; 15(10):1147-54. PubMed ID: 15485438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New fields of research in pharmacological antiarrhythmic therapy].
    Hatem S
    Arch Mal Coeur Vaiss; 2004 Nov; 97(11):1054-7. PubMed ID: 15609906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Arrhythmogenic effects of anti-arrhythmia agents].
    Pfeiffer D; Rostock KJ; Rathgen K; Schirdewan A; Kleiner HJ
    Z Gesamte Inn Med; 1987 Jul; 42(14):390-4. PubMed ID: 3673134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Inflammation of the myocardium as an arrhythmia trigger].
    Klein RM; Vester EG; Brehm MU; Dees H; Picard F; Niederacher D; Beckmann MW; Strauer BE
    Z Kardiol; 2000; 89 Suppl 3():24-35. PubMed ID: 10810782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New drugs for treatment of ventricular arrhythmias.
    Heger JJ; Prystowsky EN; Zipes DP
    Heart Lung; 1981; 10(3):475-83. PubMed ID: 6785255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Validity of the study of the electrophysiological effects of anti-arrhythmia drugs in man prior to modern antiarrhythmic therapy. Multicenter study].
    Disertori M; Furlanello F; Botti G; Bonatti V; Critelli G; Adinolfi L; Lotto A; Finzi A; Masoni A; Alboni P; Rizzon P; Di Biase M; Salerno JA; Chimienti M; Costantini M; Santini M; Dini P
    Boll Soc Ital Cardiol; 1980; Suppl():101-15. PubMed ID: 6760884
    [No Abstract]   [Full Text] [Related]  

  • 39. [Anti-arrhythmic effect of dazolicin. Clinical-pharmacological research].
    Beck OA; Spielmann H; Witt E; Oeff M; Liddard C; Hochrein H
    Arzneimittelforschung; 1980; 30(12):2172-81. PubMed ID: 7194081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac arrhythmias: the role of pharmacologic intervention.
    Klitzner TS; Friedman WF
    Cardiol Clin; 1989 May; 7(2):299-318. PubMed ID: 2659176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.